Patents by Inventor Shavej Ahmad

Shavej Ahmad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12161761
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: December 10, 2024
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Publication number: 20230058942
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Application
    Filed: October 24, 2022
    Publication date: February 23, 2023
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Patent number: 11510878
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: November 29, 2022
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Publication number: 20210106537
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Patent number: 10898444
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: January 26, 2021
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Publication number: 20180344653
    Abstract: The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
    Type: Application
    Filed: January 24, 2018
    Publication date: December 6, 2018
    Inventors: Harinder Singh, Shavej Ahmad, Romi B. Singh
  • Patent number: 10137094
    Abstract: The present invention relates to novel gastroretentive dosage systems, in particular, a floating capsule which releases the drug without any lag time and which remains buoyant for a sufficient period of time in the stomach. Further, the invention relates to the process of preparation thereof.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: November 27, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh
  • Patent number: 9861585
    Abstract: The present invention relates to an osmotic floating tablet comprising: (i) an inner core comprising a drug, one or more low density polymers, and one or more pharmaceutically acceptable excipients; and (ii) an outer osmotic coating surrounding the inner core that is substantially permeable to surrounding fluids and substantially impermeable to the drug. The present invention also relates to processes for the preparation of said tablets.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: January 9, 2018
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh, Ajay Kumar Singla
  • Patent number: 9682081
    Abstract: The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is further related to methods of preparing said dosage form.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: June 20, 2017
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Anuj Kumar Fanda, Ravish Sharma, Kumaravel Vivek, Lalit Kumar Khurana, Shavej Ahmad, Romi Barat Singh, Ajay Kumar Singla
  • Publication number: 20160338949
    Abstract: The present invention relates to stabilized gastroretentive tablets comprising pregabalin, one or more swellable polymers, a pH modifier, and other pharmaceutically acceptable excipients. It also relates to processes for the preparation of said stabilized gastroretentive tablets of pregabalin.
    Type: Application
    Filed: January 26, 2015
    Publication date: November 24, 2016
    Inventors: Varinder KUMAR, Shavej AHMAD, Romi Barat SINGH, Kaushal NAYYAR, Mohan PRASAD
  • Patent number: 9393205
    Abstract: The present invention relates to a gastroretentive tablet comprising pregabalin, at least one swellable polymer, and other pharmaceutically acceptable excipients. It further relates to a process for the preparation of same.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: July 19, 2016
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh
  • Publication number: 20160193155
    Abstract: The present invention relates to pulsatile-release dosage forms wherein said dosage forms provide pH-independent pulsatile-release of a drug after a predetermined lag time. It also relates to processes for the preparation of said pulsatile-release dosage forms.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 7, 2016
    Inventors: Vivek SHARMA, Varinder KUMAR, Lalit Kumar KHURANA, Shavej AHMAD, Romi Barat SINGH, Ajay Kumar SINGLA
  • Publication number: 20160106748
    Abstract: The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is further related to methods of preparing said dosage form.
    Type: Application
    Filed: April 25, 2014
    Publication date: April 21, 2016
    Inventors: Anuj Kumar FANDA, Ravish SHARMA, Kumaravel VIVEK, Lalit Kumar KHURANA, Shavej AHMAD, Romi Barat SINGH, Ajay Kumar SINGLA
  • Publication number: 20150231084
    Abstract: The present invention relates to an osmotic floating tablet comprising: (i) an inner core comprising a drug, one or more low density polymers, and one or more pharmaceutically acceptable excipients; and (ii) an outer osmotic coating surrounding the inner core that is substantially permeable to surrounding fluids and substantially impermeable to the drug. The present invention also relates to processes for the preparation of said tablets.
    Type: Application
    Filed: October 15, 2013
    Publication date: August 20, 2015
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh, Ajay Kumar Singla
  • Publication number: 20150025146
    Abstract: The present invention relates to a gastroretentive tablet comprising pregabalin, at least one swellable polymer, and other pharmaceutically acceptable excipients. It further relates to a process for the preparation of same.
    Type: Application
    Filed: January 29, 2013
    Publication date: January 22, 2015
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh
  • Publication number: 20140378545
    Abstract: The present invention relates to a gastroretentive tablet comprising pregabalin, an acrylic acid polymer, one or more swellable polymers, and other pharmaceutically acceptable excipients. It further relates to a process for the preparation of same.
    Type: Application
    Filed: January 29, 2013
    Publication date: December 25, 2014
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh
  • Publication number: 20140271846
    Abstract: The present invention relates to novel gastroretentive dosage systems, in particular, a floating capsule which releases the drug without any lag time and which remains buoyant for a sufficient period of time in the stomach. Further, the invention relates to the process of preparation thereof.
    Type: Application
    Filed: October 11, 2012
    Publication date: September 18, 2014
    Applicant: Ranbaxy Laboratories Limited
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh